Neurocrine Biosciences Inc. Stock Performance
as on August 5, 2026 at 6:15 am IST
Day's Low
Day's High
$166.48$169.01
0.20%
Downside
1.31%
Upside
52 Week's Low
52 Week's High
$122.14$186.1226.78%
Downside
11.57%
Upside
Neurocrine Biosciences Inc. share price movements today
- Previous Close
- $166.23
- Open
- $167.38
- Volume
- 549.4K
- Day's Low - High
- $166.48 - $169.01
- 52 Week Low - High
- $122.14 - $186.12
Neurocrine Biosciences Inc. Historical Returns
- 1 Month Return
- -4.61 %
- 3 Month Return
- + 23.08 %
- 1 Year Return
- + 29.47 %
- 3 Year Return
- + 63.56 %
- 5 Year Return
- + 79.34 %
Neurocrine Biosciences Inc. Stock Fundamentals & Key Indicators
Check Neurocrine Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$16.8B
EPS (TTM)
10.097
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.31%
PE Ratio (TTM)
24.39
Industry PE ratio
13.425714285714285
PEG Ratio
0.4706
EBITDA
913.3M
Revenue (TTM)
3.4B
Profit Margin
20.91%
Return On Equity TTM
22.09%
Neurocrine Biosciences Inc. Stock Valuation
Track how Neurocrine Biosciences Inc. P/E has moved over time to understand its valuation trends.
Neurocrine Biosciences Inc. in the last 5 years
Lowest (17.37x)
March 31, 2026
Industry (13.43x)
August 5, 2026
Today (24.39x)
August 5, 2026
Highest (52.64x)
March 31, 2022
Today’s Price to Earnings Ratio: 24.39x
Neurocrine Biosciences Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurocrine Biosciences Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $16.8B | 79.34% | 24.39 | 20.91% | NA | |
| BUY | $25.7B | 150.53% | 19.11 | 40.62% | NA | |
| HOLD | $20.4B | 28.12% | NA | -2.04% | 2.7% | |
| BUY | $43.2B | NA | 20.42 | 14.55% | 1.96% | |
| BUY | $32.4B | -62.35% | 12.67 | 28.04% | 2.67% |
Stock Returns calculator for Neurocrine Biosciences Inc. Stock including INR - Dollar returns
The Neurocrine Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Neurocrine Biosciences Inc. investment value today
Current value as on today
₹1,41,339
Returns
₹41,339
(+41.34%)
Returns from Neurocrine Biosciences Inc. Stock
₹29,932 (+29.93%)
Dollar Impact
₹11,407 (+11.41%)
Analyst Recommendation on Neurocrine Biosciences Inc. Stock
Based on 34 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Neurocrine Biosciences Inc.. Average target price of $211.09
Neurocrine Biosciences Inc. Share Price Target
Get share price movements and forecasts by analysts on Neurocrine Biosciences Inc..
What analysts predicted
20.97%UPSIDE
Target Price
$211.09
Current Price
$166.82
Analyzed by
34 Analysts
Target
$211.09
Neurocrine Biosciences Inc. target price $211.09, a slight upside of 20.97% compared to current price of $166.82. According to 34 analysts rating.
Indian Investors' Interest in Neurocrine Biosciences Inc. Stock
Search interest for Neurocrine Biosciences Inc. Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:6% versus previous 30 day period
Neurocrine Biosciences Inc. Quarterly Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc. Annual Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc. Quarterly Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc. Annual Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc. News & Key Events
Today's Timeline - 21 July
Tue, 09:01 PM
-Neurocrine has an Earnings ESP of +40.60% and Zacks Rank #1, with expected significant EPS growth.
Wed, 01:35 AM
-Neurocrine appoints Samir Siddhanti as Chief Business Officer to lead enterprise growth strategy and oversee business development.
Insights on Neurocrine Biosciences Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 6 quarters, 572.60M → 958.99M (in $), with an average increase of 9.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 66.5% return, outperforming this stock by 2.9%
- NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. Common Stock has given 97.2% return, outperforming this stock by 67.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 197.89M → 144.39M (in $), with an average decrease of 27.0% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, NBIX stock has moved down by -9.1%
About Neurocrine Biosciences Inc.
| Organisation | Neurocrine Biosciences Inc. |
| Headquarters | 6027 Edgewood Bend Court, San Diego, CA, United States, 92130 |
| Industry | Drug Manufacturers - Specialty & Generic |
| CEO | Mr. Kyle W. Gano Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Neurocrine Biosciences Inc.
Name | Title |
|---|---|
Mr. Matthew C. Abernethy CPA | Chief Financial Officer |
Dr. Jude Onyia Ph.D. | Chief Scientific Officer |
Mr. Eric S. Benevich | Chief Commercial Officer |
Dr. Eiry Wyn Roberts M.D. | Strategic Advisor |
Dr. Sanjay Keswani B.Sc., M.D., MBBS | Chief Medical Officer |
Dr. Wylie W. Vale Ph.D. | Co-Founder |
Mr. Aaron Vosburgh | Senior Vice President of Finance & Accounting |
Mr. Kyle W. Gano Ph.D. | President, CEO & Director |
Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder of Neurocrine |
Mr. Lewis Choi | Chief Information Officer |
FAQs
What is Neurocrine Biosciences Inc. share price today?
Neurocrine Biosciences Inc. share price today is $166.82 as on . Neurocrine Biosciences Inc. share today touched a day high of $169.01 and a low of $166.48.
What is the 52 week high and 52 week low for Neurocrine Biosciences Inc. share?
Neurocrine Biosciences Inc. share touched a 52 week high of $186.12 on and a 52 week low of $122.14 on . Neurocrine Biosciences Inc. stock price today i.e. is trending at $166.82,which is 10.37% down from its 52 week high and 36.58% up from its 52 week low.
What is Neurocrine Biosciences Inc.'s market capitalisation today?
Neurocrine Biosciences Inc. market capitalisation is $0.02T as on .
How to invest in Neurocrine Biosciences Inc. Stock (NBIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurocrine Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurocrine Biosciences Inc. Shares that will get you 0.0090 shares as per Neurocrine Biosciences Inc. share price of $166.82 per share as on August 5, 2026 at 12:45 am IST.
What is the minimum amount required to buy Neurocrine Biosciences Inc. Stock (NBIX) from India?
Indian investors can start investing in Neurocrine Biosciences Inc. (NBIX) shares with as little as ₹95.3775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.77 in Neurocrine Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurocrine Biosciences Inc. share’s latest price of $166.82 as on August 5, 2026 at 12:45 am IST, you will get 0.0599 shares of Neurocrine Biosciences Inc.. Learn more about
fractional shares .
What are the returns that Neurocrine Biosciences Inc. has given to Indian investors in the last 5 years?
Neurocrine Biosciences Inc. stock has given 79.34% share price returns and 28.53% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?